Atea Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Atea Pharmaceuticals, Inc. (AVIR) had Operating Lease Right-of-Use Assets of $320.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $320.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $478.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $634.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $789.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $320.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $478.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $634.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $789.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $942.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.24M 10-K · filed 2026-03-05 |
| 2024-09-30 | $1.39M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.54M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.68M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.83M 10-K · filed 2025-03-06 |
| 2023-09-30 | $1.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.11M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.25M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $2.39M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.53M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.69M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.89M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $161.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $227.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $293.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $356.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |